120 related articles for article (PubMed ID: 8814990)
1. Membrane type-matrix metalloproteinase and tumor invasion.
Seiki M
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():23-32. PubMed ID: 8814990
[No Abstract] [Full Text] [Related]
2. Complex roles of matrix metalloproteinases in tumor progression.
Powell WC; Matrisian LM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():1-21. PubMed ID: 8814982
[No Abstract] [Full Text] [Related]
3. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL; VanMeter TE; Broaddus WC
J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
[TBL] [Abstract][Full Text] [Related]
4. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
5. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
6. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
Butler GS; Will H; Atkinson SJ; Murphy G
Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases: a review.
Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
[TBL] [Abstract][Full Text] [Related]
10. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
Ray JM; Stetler-Stevenson WG
Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
12. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis.
Tokuraku M; Sato H; Murakami S; Okada Y; Watanabe Y; Seiki M
Int J Cancer; 1995 Oct; 64(5):355-9. PubMed ID: 7591310
[TBL] [Abstract][Full Text] [Related]
13. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A
Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512
[TBL] [Abstract][Full Text] [Related]
14. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H; Takino T; Okada Y; Cao J; Shinagawa A; Yamamoto E; Seiki M
Nature; 1994 Jul; 370(6484):61-5. PubMed ID: 8015608
[TBL] [Abstract][Full Text] [Related]
15. Tumor invasion, proteolysis, and angiogenesis.
Thorgeirsson UP; Lindsay CK; Cottam DW; Gomez DE
J Neurooncol; 1994; 18(2):89-103. PubMed ID: 7525888
[TBL] [Abstract][Full Text] [Related]
16. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases. A mini-review.
Nagase H
Contrib Nephrol; 1994; 107():85-93. PubMed ID: 8004978
[No Abstract] [Full Text] [Related]
18. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitors of metalloproteinases: role in tumor progression.
De Clerck YA; Alvarez O; Shimada H; Taylor SM; Langley KE
Contrib Nephrol; 1994; 107():108-15. PubMed ID: 8004956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
